HK1143379B - 半胱氨酸改造的抗tenb2抗體和抗體藥物共軛物 - Google Patents
半胱氨酸改造的抗tenb2抗體和抗體藥物共軛物 Download PDFInfo
- Publication number
- HK1143379B HK1143379B HK10109905.3A HK10109905A HK1143379B HK 1143379 B HK1143379 B HK 1143379B HK 10109905 A HK10109905 A HK 10109905A HK 1143379 B HK1143379 B HK 1143379B
- Authority
- HK
- Hong Kong
- Prior art keywords
- antibody
- tenb2
- cancer
- cysteine engineered
- cysteine
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98141107P | 2007-10-19 | 2007-10-19 | |
| US60/981,411 | 2007-10-19 | ||
| PCT/US2008/080102 WO2009052249A1 (en) | 2007-10-19 | 2008-10-16 | Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HK1143379A1 HK1143379A1 (zh) | 2010-12-31 |
| HK1143379B true HK1143379B (zh) | 2014-08-01 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2209808B1 (en) | Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates | |
| USRE47194E1 (en) | Cysteine engineered anti-MUC16 antibodies and antibody drug conjugates | |
| RU2587621C2 (ru) | АНТИТЕЛА К FcRH5, ИХ ИММУНОКОНЪЮГАТЫ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| TWI640535B (zh) | 抗-cd79b抗體及免疫共軛物及使用方法 | |
| US20170362318A1 (en) | Compositions and methods for the treatment of tumor hematopoietic origin | |
| SG183023A1 (en) | Anti-cd79b antibodies and immunoconjugates and methods of use | |
| HK1143379B (zh) | 半胱氨酸改造的抗tenb2抗體和抗體藥物共軛物 | |
| HK1182721A1 (zh) | 抗體和免疫偶聯物及其用途 |